Voyageur Pharmaceuticals Ltd has seen a notable decline in its stock performance this week.
Voyageur Pharmaceuticals Ltd (VM.V) has struggled in the market, experiencing a drop of 10.71% over the past week. With no specific company news to explain this movement, we’ll take a closer look at the technical indicators and overall market sentiment surrounding the stock.
Advertisement
Voyageur Pharmaceuticals Ltd
VM.V
VM.V
Voyageur Pharmaceuticals Ltd
WealthAwesomeMarket cap
$28.29M
52W high
$0.20
52W low
$0.07
1W change
-10.71%
Beta
0.46
Analyst Price Targets
Based on analyst covering VM · as of Sep 17, 2026
Wall Street analysts forecast VM stock price to rise 340.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.55
+340.0% Upside
Current Price
C$0.13
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on VM's historical volatility
30-Day Vol
55.3%
Annualized
90-Day Vol
84.8%
Annualized
Trend (90d)
-32.3%
Annualized drift
90d Mean
C$0.11
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.12 | C$0.10 – C$0.15 |
| 60 trading days | C$0.12 | C$0.09 – C$0.15 |
| 90 trading days | C$0.11 | C$0.08 – C$0.15 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should consider the recent price action and technical indicators when evaluating Voyageur Pharmaceuticals Ltd. The stock's performance appears weak, with significant declines over the past month, and analysts remain cautiously optimistic despite the current challenges.
Voyageur Pharmaceuticals Ltd's stock down 10.71% this week.
With the stock currently trading at C$0.13, it is positioned 44% within its 52-week range of C$0.07 to C$0.20.
Bull case
Analysts are optimistic, setting an average target price of C$0.55. This suggests there’s significant potential for the stock to rise from its current levels.
Bear case
However, the stock's recent performance, including a 26.47% decline year-to-date, raises concerns about its sustainability and how the market perceives it.
Recent Price Action
Advertisement
Voyageur Pharmaceuticals Ltd (VM.V) closed at C$0.13, down 3.85% on the day and 10.71% for the week. This downward trend has contributed to a year-to-date decline of 26.47%, reflecting broader challenges faced by the company.
Technical Picture
The stock is currently trading below both its 50-day moving average (C$0.15) and 200-day moving average (C$0.14), suggesting a bearish trend. The stock has a beta of 0.46, indicating lower volatility compared to the market. With a 52-week range of C$0.07 to C$0.20, the stock is currently at 44% of its range. The latest trading volume of 59,020 shares is significantly below the 20-day average of 114,714 shares, at just 0.37 times the average volume.
Market Sentiment
Despite the current downward pressure on the stock, analysts maintain an average target of C$0.55, suggesting a bullish outlook with an implied move of 340% from its current price. This indicates that there is potential for recovery, although the recent performance raises questions about the company's immediate prospects.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
